These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 14712615)

  • 1. Cost of musculoskeletal diseases: impact of work disability and functional decline.
    Yelin E
    J Rheumatol Suppl; 2003 Dec; 68():8-11. PubMed ID: 14712615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, utilization, and costs associated with acute respiratory conditions, United States, 1980.
    Harlan WR; Murt HA; Thomas JW; Lepkowski JM; Guire KE; Parsons PE; Berki SE; Landis JR
    Natl Med Care Util Expend Surv C; 1986 Sep; (4):1-63. PubMed ID: 10313514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates.
    Yelin E; Cisternas MG; Pasta DJ; Trupin L; Murphy L; Helmick CG
    Arthritis Rheum; 2004 Jul; 50(7):2317-26. PubMed ID: 15248233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the costs of work-related musculoskeletal disorders: targeting strategies to chronic disability cases.
    Baldwin ML
    J Electromyogr Kinesiol; 2004 Feb; 14(1):33-41. PubMed ID: 14759748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitions in employment, morbidity, and disability among persons ages 51-61 with musculoskeletal and non-musculoskeletal conditions in the US, 1992-1994.
    Yelin EH; Trupin LS; Sebesta DS
    Arthritis Rheum; 1999 Apr; 42(4):769-79. PubMed ID: 10211893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a musculoskeletal disability management program on medical costs and productivity in a large manufacturing company.
    Bunn WB; Baver RS; Ehni TK; Stowers AD; Taylor DD; Holloway AM; Duong D; Pikelny DB; Sotolongo D
    Am J Manag Care; 2006 Dec; 12 Spec no.():SP27-32. PubMed ID: 17173488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of rheumatoid arthritis: facts and figures.
    Callahan LF
    J Rheumatol Suppl; 1998 Jul; 53():8-12. PubMed ID: 9666412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
    Birnbaum HG; Kessler RC; Lowe SW; Secnik K; Greenberg PE; Leong SA; Swensen AR
    Curr Med Res Opin; 2005 Feb; 21(2):195-206. PubMed ID: 15801990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost impact of COPD in Japan: opportunities and challenges?
    Nishimura S; Zaher C
    Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labor market, financial, insurance and disability outcomes among near elderly Americans with depression and pain.
    Tian H; Robinson RL; Sturm R
    J Ment Health Policy Econ; 2005 Dec; 8(4):219-28. PubMed ID: 16385147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: direct and indirect costs of arthritis and other rheumatic conditions--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 May; 53(18):388-9. PubMed ID: 15138399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The earnings, income, and assets of persons aged 51-61 with and without musculoskeletal conditions.
    Yelin E
    J Rheumatol; 1997 Oct; 24(10):2024-30. PubMed ID: 9330948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to manage musculoskeletal conditions: when is 'rehabilitation' appropriate?
    Cameron ID
    Best Pract Res Clin Rheumatol; 2004 Aug; 18(4):573-86. PubMed ID: 15301987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists.
    Guillemin F; Durieux S; Daurès JP; Lafuma A; Saraux A; Sibilia J; Bourgeois P; Sany J
    J Rheumatol; 2004 Jul; 31(7):1297-304. PubMed ID: 15229947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database.
    Joish VN; Donaldson G; Stockdale W; Oderda GM; Crawley J; Sasane R; Joshua-Gotlib S; Brixner DI
    Curr Med Res Opin; 2005 Apr; 21(4):535-44. PubMed ID: 15899102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic cost and social and psychological impact of musculoskeletal conditions. National Arthritis Data Work Groups.
    Yelin E; Callahan LF
    Arthritis Rheum; 1995 Oct; 38(10):1351-62. PubMed ID: 7575685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of a continuum of care model on the rehabilitation of compensation claimants with soft tissue disorders.
    Stephens B; Gross DP
    Spine (Phila Pa 1976); 2007 Dec; 32(25):2898-904. PubMed ID: 18246015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Musculoskeletal imaging: medicare use, costs, and potential for cost substitution.
    Parker L; Nazarian LN; Carrino JA; Morrison WB; Grimaldi G; Frangos AJ; Levin DC; Rao VM
    J Am Coll Radiol; 2008 Mar; 5(3):182-8. PubMed ID: 18312965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic cost of dementia patients according to the limitation of the activities of daily living in Korea.
    Kang IO; Lee SY; Kim SY; Park CY
    Int J Geriatr Psychiatry; 2007 Jul; 22(7):675-81. PubMed ID: 17171741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.